Mrs Judith Ann Dyrenforth, SPEECH PATHOLOGIST in Fairbanks, AK - Speech-Language Pathologist

Mrs Judith Ann Dyrenforth, SPEECH PATHOLOGIST is a Speech-language Pathologist based in Fairbanks, Alaska. Mrs Judith Ann Dyrenforth is licensed to practice in Alaska (license number 460) and her current practice location is 398 Hamilton Ave, Fairbanks, Alaska. She can be reached at her office (for appointments etc.) via phone at (907) 374-4911.

NPI number for Mrs Judith Ann Dyrenforth is 1235466749 and her current mailing address is 398 Hamilton Ave, Fairbanks, Alaska. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1235466749.

Contact Information

	Mrs Judith Ann Dyrenforth, SPEECH PATHOLOGIST
	398 Hamilton Ave, Fairbanks, AK 99701-3537
	(907) 374-4911
	(907) 374-4934

Healthcare Provider's Profile

Full Name	Mrs Judith Ann Dyrenforth
Gender	Female
Speciality	Speech-language Pathologist
Location	398 Hamilton Ave, Fairbanks, Alaska
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1235466749
Provider Enumeration Date: 11/05/2009
Last Update Date: 10/17/2013

Medical Identifiers

Medical identifiers for Mrs Judith Ann Dyrenforth such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1235466749	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
235Z00000X	Speech-language Pathologist	SP-1944 (Maine)	Secondary
235Z00000X	Speech-language Pathologist	460 (Alaska)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mrs Judith Ann Dyrenforth is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mrs Judith Ann Dyrenforth, SPEECH PATHOLOGIST 398 Hamilton Ave, Fairbanks, AK 99701-3537 Ph: (907) 374-4911	Mrs Judith Ann Dyrenforth, SPEECH PATHOLOGIST 398 Hamilton Ave, Fairbanks, AK 99701-3537 Ph: (907) 374-4911

News Archive

ACCC releases preliminary results from survey on stage III and IV lung cancer care

The Association of Community Cancer Centers today released preliminary results and an initial set of quality care recommendations from Fostering Excellence in Care and Outcomes in Patients with Stage III and IV NSCLC, an initiative to improve care delivery and outcomes for advanced non-small cell lung cancer (NSCLC) patients.

Clinical study results show no increased risk of CV events associated with SYMLIN injection

Amylin Pharmaceuticals, Inc. today announced results from an analysis of an integrated database of clinical studies that showed no increased risk of cardiovascular events associated with SYMLIN (pramlintide acetate) injection use compared to a pooled comparator group treated with either placebo or rapid-acting insulin. These findings were presented at the 70th Annual Scientific Sessions of the American Diabetes Association in Orlando, Fla.

Researchers to develop a highly sensitive, portable method of detecting bioterror agents like anthrax

Their method uses "Cellular Analysis and Notification of Antigen Risks and Yields" (CANARY) cells, which are immune-system cells engineered to contain a fluorescent protein naturally found in jellyfish. CANARY cells have the immune system's ability to detect specific disease-causing agents, lighting up when they recognize a pathogen.

Caution against over-intensive BP control in diabetes patients

Very intensive control of blood pressure in patients with Type 2 diabetes does not prevent cognitive decline and may even be counterproductive, suggest findings from the ACCORD MIND substudy.

AbbVie doses first subject in adalimumab clinical trial using Halozyme's ENHANZE technology

Halozyme Therapeutics, Inc. today announced that AbbVie has dosed the first subject in a clinical trial evaluating the safety and pharmacokinetics of adalimumab with Halozyme's proprietary ENHANZE technology.

Speech-Language Pathologist in Fairbanks, AK

Mrs. Kathleen Forehand Hall, CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1327 Kalakaket Street, Fairbanks, AK 99709 Phone: 907-452-4517 Fax: 907-452-4263
Conversation Station Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 600 University Ave Ste 110, Fairbanks, AK 99709 Phone: 907-687-6309
Ms. Heather E Eisenman, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1528 Bluegrass Dr, Fairbanks, AK 99709 Phone: 707-364-2013
Kerry Rae Pippin, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 415 1st Ave, Fairbanks, AK 99701 Phone: 907-347-6494
David Jamison, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1327 Kalakaket St, Fairbanks, AK 99709 Phone: 907-452-4517
Mrs. Melinda Alexandria Mihalich, CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1327 Kalakaket Street, Fairbanks, AK 99709 Phone: 907-452-4517 Fax: 907-452-4263
Mackenzee Heath, SLP-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 140 Chapman Ct, Fairbanks, AK 99709 Phone: 907-374-1686 Fax: 866-308-4995

Mrs Judith Ann Dyrenforth, SPEECH PATHOLOGIST - Speech-Language Pathologist in Fairbanks, AK